Vulnerability in Biotronik Cardiomessenger Ii-S Gsm

CVE-2019-18254

BIOTRONIK CardioMessenger II, The affected products do not encrypt sensitive information while at rest. An attacker with physical access to the CardioMessenger can disclose medical measurement data and the serial number from the implanted cardiac device the CardioMessenger is paired with.

Published · last modified .

CVSS v3 metric

CVSS v3 base score 4.6 (Medium). Vector: CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N.

EPSS exploit prediction

EPSS: 0.002 (11.9th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 12th percentile — 11.9% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2019-18254: held from 0.002 to 0.002.

EPSS over last 30 days · oldest: 0.002 · newest: 0.002 · change: -0.000

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2019-18254?
CVE-2019-18254 is a medium-severity vulnerability in Biotronik Cardiomessenger Ii-S Gsm, classified under Missing Encryption of Sensitive Data. CVSS score: 4.6/10. Published 2020-06-29.
How severe is CVE-2019-18254?
Medium severity. CVSS v3 base score is 4.6 out of 10.